Risk factors for rifampicin-susceptible and isoniazid-resistant tuberculosis in adult patients with type 2 diabetes mellitus in Nanjing

被引:0
作者
Guo, Jing [1 ,2 ]
Feng, Xuebing [2 ]
Pang, Jialei [3 ]
Li, Wenchao [2 ]
Cai, Min [4 ]
Cao, Zhiyun [1 ]
Lin, Feishen [1 ]
Zhang, Xia [1 ]
机构
[1] Nanjing Univ Chinese Med, Hosp Nanjing 2, Dept TB, Nanjing 211132, Peoples R China
[2] Nanjing Univ Chinese Med, Dept Rheumatol & Immunol, Nanjing Drum Tower Hosp, Clin Coll, Nanjing 210008, Peoples R China
[3] Nanjing Med Univ, Dept Intens Care Unit, Nanjing Chest Hosp, Affiliated Brain Hosp, Nanjing 210029, Peoples R China
[4] Nanjing Univ Chinese Med, Hosp Nanjing 2, Dept Inst Off, Nanjing 211132, Peoples R China
关键词
Tuberculosis; Type 2 diabetes mellitus; Isoniazid-resistant and rifampicin-susceptible tuberculosis; Isoniazid-resistant tuberculosis; Risk factor; Iron; DRUG-RESISTANCE;
D O I
10.1186/s12879-025-10709-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective Globally, Tuberculosis(TB) with type 2 diabetes mellitus (T2DM) is becoming increasingly serious, especially the emergence of rifampicin-susceptible and isoniazid-resistant tuberculosis (Hr-TB), which increases the difficulty of treatment and the burden of disease. Therefore, this single-center retrospective cohort study analyzed risk factors of Hr-TB in adult patients with T2DM and pulmonary tuberculosis (PTB) in Nanjing to guide clinical practice and improve the long-term prognosis of patients. Methods The clinical data of 279 adult inpatients diagnosed with culture-positive PTB and T2DM in the Second Hospital of Nanjing from January 2019 and December 2021 were collected. According to the drug susceptibility testing (DST) results, 44 patients with Hr-TB were categorized as the Hr-TB group, while the remaining 235 patients with drug-susceptible tuberculosis (DS-TB) were classified as DS-TB group. Hierarchical logistic regression was employed for multivariate analysis to identify variables associated with Hr-TB in patients with T2DM. Results There were no significant differences in age, sex, body mass index (BMI), smoking, drinking, ethnicity, education level, or comorbidities between the DS-TB and Hr-TB groups. Multivariate logistic regression analysis revealed that, history of previous tuberculosis treatment (OR = 2.348, 95%CI: 1.025 similar to 5.379, P = 0.044), poor FPG control (OR = 2.402, 95%CI: 1.208 similar to 4.776, P = 0.012), and serum iron levels >= 14.3 mu mol/l (OR = 2.808, 95%CI: 1.334 similar to 5.910, P = 0.007) are independent risk factors for Hr-TB in adult patients with T2DM in Nanjing. Within the cohort, 241 patients were Newly treatment tuberculosis patients, and among them, poor FPG control (OR = 2.296, 95%CI: 1.073 similar to 4.915, P = 0.032), and serum iron levels >= 14.3 mu mol/l (OR = 2.418, 95%CI: 1.048 similar to 5.577, P = 0.038) were identified as risk factors for Hr-TB. Conclusion Poor fasting glycemic control and serum iron levels >= 14.3 mu mol/L are independent risk factors for the development of Hr-TB in adults with T2DM and PTB, moreover, the contribution of these as risk factors were more pronounced in the newly treatment tuberculosis patients subgroup than patients with a history of previous tuberculosis treatment. History of previous tuberculosis treatment was also found to be a risk factor for Hr-TB in adults with T2DM. Clinical trial number Not applicable.
引用
收藏
页数:8
相关论文
共 35 条
  • [1] Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis
    Abreu, Rodrigo
    Giri, Pramod
    Quinn, Fred
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [2] [Anonymous], 2019, WHO Guidelines on tuberculosis infection prevention and control 2019 Update
  • [3] Antituberculosis, 2021, J Chin Antituberculosis Association, V43, P12
  • [4] Isoniazid Monoresistance and Antituberculosis Treatment Outcome in Persons With Pulmonary Tuberculosis in Brazil
    Araujo-Pereira, Mariana
    Arriaga, Maria B.
    Carvalho, Anna Cristina C.
    Spener-Gomes, Renata
    Schmaltz, Carolina A. S.
    Nogueira, Betania M. F.
    Figueiredo, Marina C.
    Turner, Megan M.
    Cordeiro-Santos, Marcelo
    Rolla, Valeria C.
    Sterling, Timothy R.
    Andrade, Bruno B.
    Kritski, Afranio L.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (01):
  • [5] The ABC exporter IrtAB imports and reduces mycobacterial siderophores
    Arnold, Fabian M.
    Weber, Miriam S.
    Gonda, Imre
    Gallenito, Marc J.
    Adenau, Sophia
    Egloff, Pascal
    Zimmermann, Iwan
    Hutter, Cedric A. J.
    Huerlimann, Lea M.
    Peters, Eike E.
    Piel, Joern
    Meloni, Gabriele
    Medalia, Ohad
    Seeger, Markus A.
    [J]. NATURE, 2020, 580 (7803) : 413 - +
  • [6] WHO's Global Tuberculosis Report 2022
    Bagcchi, Sanjeet
    [J]. LANCET MICROBE, 2023, 4 (01): : E20 - E20
  • [7] The effect of the host's iron status on tuberculosis
    Boelaert, Johan R.
    Vandecasteele, Stefaan J.
    Appelberg, Rui
    Gordeuk, Victor R.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (12) : 1745 - 1753
  • [8] Chinese Anti-tuberculosis Association, 2015, Rules for laboratory examination of tuberculosis
  • [9] Interdependence of mycobacterial iron regulation, oxidative-stress response and isoniazid resistance
    Dussurget, O
    Smith, I
    [J]. TRENDS IN MICROBIOLOGY, 1998, 6 (09) : 354 - 358
  • [10] FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1